Organiser

Aleš Svatos, Max Planck Institute for Chemical Ecology, Jena, Germany

Introduction

Proteomics, which stands on a foundation laid by genomics, is an extension of transcriptomic studies. In addition to rather organism life-time static genetic information, proteomics offers a picture of every-moment dynamic of proteins, their synthesis, post-translation processing and modifications, as well as their degradation. Proteomics has gradually become a part of medical diagnosis (biomarkers) as well as an important tool for studying organism development, regulation and defense reaction towards abiotic and biotic factors.

Proteomics, like other “omics” techniques, depends heavily on advanced analytical technology. The instrumentation is very expensive and needs substantial resources from individual countries. This is one of the reasons why the proteomics technology in former East European countries and in central Europe was delayed compared to the USA or Western Europe. However, not only is the technology delay substantial, but communication among laboratories in and within the eastern countries is infrequent and sporadic. The oldest national proteomics societies (France, Germany and Switzerland ) were established around 2000, in Eastern and central European countries, not earlier than 2004. The European Proteomic Association was established only in 2005. National societies regularly organise small annual meetings, and several huge international meetings such as HUPO or ASMS (2,000-5,000 participants) take place; however, medium-sized conferences, where people from the same region can meet and not be held back by long distances, do not exist. Recently the “ Central and Eastern Proteomic Conference ” series was launched by Czech, Swiss, Italian, German, Slovak, Hungarian and Russian scientists, and the first meeting will be held in Prague in October 2007.

We believe that the further development of proteomics in Europe is impossible unless the diffusion and exchange of information among people in Europe interested in proteomics is also promoted. We strongly believe that medium-sized conferences held in a different country each year will stimulate and deepen research and collaboration.

Preliminary Programme

•  Synthetic biology

Mathias Mann (MPI for Biochemistry, Germany)

•  Clinical proteomics

Helmut Meyer (Medical Proteome Center, Bochum, Germany) confirmed

•  New technology for high throughput clinical proteomics

Roman Zubarev (Uppsala University, Swede ) confirmed

•  Spatially-resolved proteomics, imaging of biomarkers

Richard Caprioli (Vanderbilt University, USA) confirmed

•  Glycomics, Glycoproteins and Diseases

Jasna Peter-Katalinic (Münster University, Germany) confirmed

•  Disease proteomics

Jennifer van Eyk (Johns Hopkins University, Baltimore)

Mike Dunn (Conway Institute, Dublin, Ireland)

•  Quantitative proteomics

Friedrich Lottspeich (MPI for Biochemistry, Martinsried, Germany)

Venue

The conference will be held in Jena at the Max Planck Institute for Chemical Ecology on the Beutenberg Campus.

Jena is an historical city where literary geniuses Goethe and Schiller once lived as well as optical and manufacturing giants Zeiss, Abbe, and Schott. Additionally, Jena was named the “Stadt der Wissenschaft 2008,” a prestigious title awarded the city that has made the most scientific and technological advances in all Germany .

Registration

Registration is now closed .